Search for dissertations about: "BFR"
Showing result 1 - 5 of 14 swedish dissertations containing the word BFR.
-
1. Linking exposure pathways to internal concentrations of brominated flame retardants in Swedish mothers and their toddlers
Abstract : Brominated flame retardants (BFRs) have been used in a variety of consumer products to enhance their fire safety. This has resulted in exposure of the environment, wildlife and humans causing risks of endocrine disruption. READ MORE
-
2. Cerebral blood flow distribution, collateral function and pulsatility in healthy and in patients with symptomatic carotid stenosis : a magnetic resonance imaging approach
Abstract : Background: For the detection and treatment of early cerebral vascular disease it is of paramount importance to first understand the normal physiology of the cerebral vasculature, and subsequently, to understand how and when pathology can develop from that. This is especially important as the population above 65 years of age is increasing and aging itself is an established risk factor for the development of cerebral vascular disease. READ MORE
-
3. Toxicity of brominated flame retardants with focus on retinoid system disturbances
Abstract : Background: Brominated flame retardants (BFR) are detected in the environment and biota all over the world. They contribute to the human body burden of industrial chemicals and exposure is mainly via food. Indoor dust contributes substantially in some exposure situations, which involve small children. READ MORE
-
4. Environmental occurrence and behaviour of the flame retardant decabromodiphenyl ethane
Abstract : The environmental occurrence and behaviour of the brominated flame retardant (BFR) decabromodiphenyl ethane (dbdpe) has only been studied to a limited extent. It is structurally similar to decabromodiphenyl ether (decaBDE), which makes it conceivable that dbdpe may also become an environmental contaminant of concern. READ MORE
-
5. Targeted therapy and outcome in chronic lymphocytic leukemia
Abstract : Despite major advances, chronic lymphocytic leukemia (CLL) is still considered incurable. Fludarabine refractory patients and those with TP53disruptions have a particularly poor prognosis. Alemtuzumab is an established treatment option for these patients. However, its use is complicated by immunosuppressive side effects. READ MORE